Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study

Archive ouverte

Garnier, Louis | Vidal, Chrystelle | Chinot, Olivier | Cohen-Jonathan Moyal, Elisabeth | Djelad, Apolline | Bronnimann, Charlotte | Bekaert, Lien | Taillandier, Luc | Frenel, Jean-Sébastien | Langlois, Olivier | Colin, Philippe | Menei, Philippe | Dhermain, Frédéric | Carpentier, Catherine | Gerazime, Aurélie | Curtit, Elsa | Figarella-Branger, Dominique | Dehais, Caroline | Ducray, François

Edité par CCSD ; Oxford University Press -

International audience. Background Anaplastic oligodendrogliomas IDH-mutant and 1p/19q codeleted (AO) occasionally have a poor outcome. Herein we aimed at analyzing their characteristics. Methods We retrospectively analyzed the characteristics of 44 AO patients with a cancer-specific survival <5 years (short-term survivors, STS) and compared them with those of 146 AO patients with a survival ≥5 years (classical survivors, CS) included in the POLA network. Results Compared to CS, STS were older (P = .0001), less frequently presented with isolated seizures (P < .0001), more frequently presented with cognitive dysfunction (P < .0001), had larger tumors (P = .= .003), a higher proliferative index (P = .= .0003), and a higher number of chromosomal arm abnormalities (P = .= .02). Regarding treatment, STS less frequently underwent a surgical resection than CS (P = .= .0001) and were more frequently treated with chemotherapy alone (P = .= .009) or with radiotherapy plus temozolomide (P = .= .05). Characteristics independently associated with STS in multivariate analysis were cognitive dysfunction, a number of mitosis > 8, and the absence of tumor resection. Based on cognitive dysfunction, type of surgery, and number of mitosis, patients could be classified into groups of standard (18%) and high (62%) risk of <5 year survival. Conclusion The present study suggests that although STS poor outcome appears to largely result from a more advanced disease at diagnosis, surgical resection may be particularly important in this population.

Suggestions

Du même auteur

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH -wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

Archive ouverte | Garnier, Louis | CCSD

International audience. In a post hoc analysis of the CATNON trial (NCT00626990), we explored whether adding temozolomide to radiotherapy improves outcome in patients with IDH1/2 wildtype (wt) anaplastic astrocytoma...

Survival outcomes associated with first-line procarbazine, CCNU, and Vincristine or Temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma

Archive ouverte | Kacimi, Salah Eddine O. | CCSD

International audience. Purpose: Patients with IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma (O3IDHmt/Codel) benefit from adding alkylating agent chemotherapy to radiotherapy (RT). However, the optimal chemo...

Incidence and Characteristics of Pseudoprogression in IDH-mutant High-Grade Gliomas: A POLA Network Study.

Archive ouverte | Seyve, Antoine | CCSD

International audience. BACKGROUND: Incidence and characteristics of pseudoprogression in isocitrate dehydrogenase-mutant high-grade gliomas (IDHmt HGG) remain to be specifically described. METHODS: We analyzed pseu...

Chargement des enrichissements...